Favorites • 0
Personal Folders
0
No personal folders
Shared folders
0
No shared folders
Nonprofit organization

Clinical Development of a Nipah Monoclonal Antibody (mAb) to Protect Against Nipah Virus (NiV) Disease

Last update: Jun 7, 2023 Last update: 07 Jun, 2023

Details

Location:Bangladesh, India, Philippines, ... See moreBangladesh, India, Philippines, Singapore
Contracting Authority Type:Nonprofit Organisation
Status:Closed
Budget:N/A
Award ceiling:N/A
Award floor:N/A
Sector:Health, Research
Languages:English
Eligible applicants:NGOs / Nonprofit Organisations, Government / Public Bodies, Academic Institutions, Research and Technology Organisations (RTOs)
Eligible nationalities:WorldwideWorldwide
Date posted:07 Jun, 2023

Attachments 2

Description

Clinical Development of a Nipah Monoclonal Antibody (mAb) to Protect Against Nipah Virus (NiV) Disease
Want to unlock full information?
Member-only information. Purchase or upgrade membership to access this information. Procurement notices from over 112+ donors and banks are available here.
Learn more about our membership benefits
Similar grants
By Locations
Funding agency:
NPO
Status:
closed
Location:
Bangladesh, Bhutan, China, India, Indonesia, Japan, Nepal, Pakistan, Philippines, Samoa, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Vietnam
Funding agency:
EC
Status:
closed
Location:
Afghanistan, Bangladesh, Bhutan, Brunei, Cambodia, China, Hong Kong, India, Indonesia, Japan, Laos, Macao, Malaysia, Maldives, Myanmar, Nepal, Pakistan, Philippines, Singapore, South Korea, Sri Lanka, Taiwan, Thailand, Timor-Leste, Vietnam

Comments • 0

This section allows you to leave comments. Only your team can view them.

Post a comment

TC